CORT - Corcept Therapeutics Incorporated
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$117.60
DETAILS
HIGH:
$165.00
LOW:
$50.00
MEDIAN:
$135.00
CONSENSUS:
$117.60
UPSIDE:
4.26%
Institutional Holders (13F)
| GURU | SHARES | VALUE | WEIGHT % | SHARES CHG | ACTION |
|---|---|---|---|---|---|
| Cooperman | 1,181,348 | $47.6M | 0.0% | +1,011,681 | INCREASED |
| Wood | 56,181 | $2.3M | 0.0% | +56,181 | NEW |
| Dalio | 38,422 | $1.5M | 0.0% | -240,578 | DECREASED |
| Greenblatt | 17,918 | $722,275 | 0.0% | +566 | INCREASED |
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-07-30 | Mokari Atabak | officer: Chief Financial Officer | M-Exempt | 80,000 | $23.06 | $1.8M |
| 2026-07-30 | Mokari Atabak | officer: Chief Financial Officer | SELL | 4,200 | $105.54 | $443K |
| 2026-07-30 | Mokari Atabak | officer: Chief Financial Officer | SELL | 8,956 | $106.96 | $958K |
| 2026-07-30 | Mokari Atabak | officer: Chief Financial Officer | SELL | 400 | $108.46 | $43K |
| 2026-07-30 | Mokari Atabak | officer: Chief Financial Officer | SELL | 2,202 | $110.03 | $242K |
| 2026-07-30 | Mokari Atabak | officer: Chief Financial Officer | SELL | 600 | $110.95 | $67K |
| 2026-07-30 | Mokari Atabak | officer: Chief Financial Officer | SELL | 4,700 | $113.18 | $532K |
| 2026-07-30 | Mokari Atabak | officer: Chief Financial Officer | SELL | 15,477 | $114.96 | $1.8M |
| 2026-07-30 | Mokari Atabak | officer: Chief Financial Officer | SELL | 14,222 | $115.87 | $1.6M |
| 2026-07-30 | Mokari Atabak | officer: Chief Financial Officer | SELL | 7,089 | $116.96 | $829K |
| 2026-07-30 | Mokari Atabak | officer: Chief Financial Officer | SELL | 8,267 | $117.93 | $975K |
| 2026-07-30 | Mokari Atabak | officer: Chief Financial Officer | SELL | 4,783 | $118.73 | $568K |
| 2026-07-30 | Mokari Atabak | officer: Chief Financial Officer | SELL | 8,103 | $119.95 | $972K |
| 2026-07-30 | Mokari Atabak | officer: Chief Financial Officer | SELL | 1,001 | $120.67 | $121K |
| 2026-07-15 | Mokari Atabak | officer: Chief Financial Officer | M-Exempt | 24,167 | $23.06 | $557K |
| 2026-07-15 | Mokari Atabak | officer: Chief Financial Officer | SELL | 7,919 | $86.78 | $687K |
| 2026-07-15 | WILSON JAMES N | director | SELL | 1,079 | $86.78 | $94K |
| 2026-07-15 | WILSON JAMES N | director | SELL | 3,969 | $87.74 | $348K |
| 2026-07-15 | WILSON JAMES N | director | SELL | 2,974 | $88.81 | $264K |
| 2026-07-15 | Mokari Atabak | officer: Chief Financial Officer | SELL | 101 | $89.43 | $9K |
| 2026-07-15 | Mokari Atabak | officer: Chief Financial Officer | M-Exempt | 15,833 | $19.26 | $305K |
| 2026-07-15 | WILSON JAMES N | director | SELL | 1,978 | $89.49 | $177K |
| 2026-07-15 | Mokari Atabak | officer: Chief Financial Officer | SELL | 28,460 | $87.89 | $2.5M |
| 2026-07-15 | Mokari Atabak | officer: Chief Financial Officer | SELL | 3,520 | $88.30 | $311K |
| 2026-07-07 | Guyer William | officer: Chief Development Officer | SELL | 952 | $93.54 | $89K |